Levon M Khachigian Selected Research

Reperfusion Injury

12/2020	Neutralizing the pathological effects of extracellular histones with small polyanions.
11/2009	c-Jun DNAzymes inhibit myocardial inflammation, ROS generation, infarct size, and improve cardiac function after ischemia-reperfusion injury.
6/2007	The streptozotocin-treated Sprague-Dawley rat: a useful model for the assessment of acute and chronic effects of myocardial ischaemia reperfusion injury in experimental diabetes.
3/2004	Modulation of growth factor gene expression in vascular cells by oxidative stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Levon M Khachigian Research Topics

Disease

25	Neoplasms (Cancer) 07/2023 - 01/2002
11	Neointima 01/2021 - 01/2002
11	Atherosclerosis 09/2012 - 03/2004
6	Melanoma (Melanoma, Malignant) 01/2024 - 05/2004
6	Neoplasm Metastasis (Metastasis) 07/2023 - 10/2005
6	Inflammation (Inflammations) 01/2020 - 12/2003
6	Hyperplasia 12/2018 - 05/2003
5	Wounds and Injuries (Trauma) 01/2020 - 08/2006
5	Vascular System Injuries 10/2019 - 08/2008
4	Reperfusion Injury 12/2020 - 03/2004
4	Myocardial Infarction 07/2013 - 11/2006
4	Osteosarcoma (Osteogenic Sarcoma) 09/2008 - 07/2008
3	Thrombosis (Thrombus) 01/2021 - 11/2006
3	Skin Neoplasms (Skin Cancer) 01/2020 - 06/2012
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 11/2009
3	Pathologic Constriction (Stenosis) 12/2018 - 02/2010
3	Fibrosis (Cirrhosis) 01/2014 - 09/2004
3	Breast Neoplasms (Breast Cancer) 09/2013 - 08/2003
3	Infarction (Infarctions) 07/2013 - 11/2009
3	Carcinogenesis 04/2008 - 09/2003
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2023 - 07/2023
2	Infections 01/2023 - 03/2008
2	Arthritis (Polyarthritis) 01/2021 - 01/2006
2	Hypoxia (Hypoxemia) 01/2018 - 06/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2016 - 06/2011
2	Basal Cell Carcinoma (Rodent Ulcer) 10/2013 - 05/2013
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2012 - 05/2009
2	Retinal Neovascularization 01/2012 - 07/2010
2	Thrombocytopenia (Thrombopenia) 10/2010 - 09/2010
2	Rheumatoid Arthritis 07/2006 - 01/2006
1	Squamous Cell Carcinoma of Head and Neck 07/2023
1	Intermittent Claudication 01/2023
1	Chronic Limb-Threatening Ischemia 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2022
1	Osteitis 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2020
1	Sepsis (Septicemia) 12/2020
1	Necrosis 11/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2018
1	ST Elevation Myocardial Infarction 01/2018

Drug/Important Bio-Agent (IBA)

21	Catalytic DNA (Deoxyribozyme)IBA 01/2019 - 06/2002
13	Transcription Factors (Transcription Factor)IBA 10/2022 - 08/2003
8	Messenger RNA (mRNA)IBA 06/2012 - 01/2004
7	Proteins (Proteins, Gene)FDA Link 07/2023 - 09/2003
7	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2020 - 01/2002
6	LigandsIBA 10/2019 - 09/2004
5	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2020 - 05/2003
5	MicroRNAs (MicroRNA)IBA 10/2019 - 09/2013
4	Small Interfering RNA (siRNA)IBA 02/2013 - 08/2006
4	Platelet-Derived Growth FactorIBA 10/2010 - 09/2004
3	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2023
3	AnthelminticsIBA 01/2023 - 10/2019
3	flubendazoleIBA 01/2023 - 10/2019
3	CytokinesIBA 01/2021 - 01/2014
3	Retinaldehyde (Retinal)IBA 01/2020 - 07/2010
3	AntibodiesIBA 01/2018 - 09/2010
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 05/2004
3	OligonucleotidesIBA 07/2013 - 09/2003
2	Programmed Cell Death 1 ReceptorIBA 01/2023 - 12/2021
2	CollagenIBA 01/2021 - 01/2006
2	Matrix Metalloproteinases (MMPs)IBA 11/2020 - 01/2012
2	matrigelIBA 01/2020 - 08/2003
2	Heme Oxygenase-1IBA 01/2018 - 12/2010
2	Caspase 3 (Caspase-3)IBA 01/2018 - 01/2018
2	Cyclin D1IBA 01/2018 - 05/2012
2	RNA (Ribonucleic Acid)IBA 04/2015 - 09/2013
2	Dz13 DNAzymeIBA 10/2013 - 05/2013
2	Thromboplastin (Tissue Factor)IBA 07/2013 - 07/2004
2	Proteoglycans (Proteoglycan)IBA 09/2012 - 09/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010 - 03/2008
2	Protein CIBA 11/2009 - 07/2006
2	NF-kappa B (NF-kB)IBA 05/2009 - 03/2008
2	ChitosanIBA 09/2008 - 07/2008
2	Chemotactic FactorsIBA 04/2008 - 09/2004
2	MitogensIBA 04/2008 - 09/2004
2	EndotoxinsIBA 07/2006 - 01/2006
2	heparanaseIBA 10/2005 - 12/2003
1	PeptidomimeticsIBA 01/2024
1	VaccinesIBA 01/2024
1	Protein Kinase InhibitorsIBA 01/2024
1	Vascular Endothelial Growth FactorsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Histones (Histone)IBA 12/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2019
1	Nucleic AcidsIBA 01/2019
1	Cytochromes c (Cytochrome c)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Superoxides (Superoxide)IBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018

Therapy/Procedure

15	Therapeutics 01/2024 - 11/2006
5	Stents 01/2021 - 01/2002
5	Percutaneous Coronary Intervention 10/2019 - 04/2007
4	Immunotherapy 01/2024 - 02/2013
3	Transplantation 12/2018 - 02/2010
1	Surgical Amputation (Amputations) 01/2023
1	Drug-Eluting Stents 01/2021
1	Lasers (Laser) 01/2020